120
Participants
Start Date
May 2, 2022
Primary Completion Date
August 4, 2023
Study Completion Date
August 4, 2023
Antiparasitic medication
"Participants in the parasite-positive group (based on positive result of either stool microscopy or stool PCR) will be administered antiparasitic treatment. Antiparasitic medication administered will be targeted to treat the parasite identified. See detailed description of protocol for medication, dose, and frequency that will be given for each parasitic infection identified.~Participants with negative stool microscopy and negative stool PCR will not be administered treatment, thus will serve as controls."
Lighthouse Clinic, Lilongwe
Fogarty International Center of the National Institute of Health
NIH
University of North Carolina, Chapel Hill
OTHER